Investor Relations
BioSig Technologies, Inc Corporate Summary
Latest Annual Report
View Annual ReportStock Information
Symbol
Nasdaq: BSGMPrice
Change
Volume
52 week Low/High
Day Low/High
Company Overview
BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace. By 2028, the EP market is expected to reach $16 billion, with an estimated 11.2% CAGR.
Investor Relations
T: (203) 409-5444 x 133
info@biosigtech.com
Transfer Agent
Securities Transfer Corporation
2901 N. Dallas Parkway
Suite 380
Plano, TX 75093
T: (469) 633-0101
F: (469) 633-0088
info@stctransfer.com
www.stctransfer.com
